NCT02386826 INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme Status COMPLETED Phase PHASE1
NCT02383251 Paclitaxel/Pazopanib for Platinum Resistant/Refractory Ovarian Cancer Status COMPLETED Phase PHASE2
NCT02382913 Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1) Status COMPLETED Phase PHASE1
NCT02379637 Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough Status COMPLETED Phase PHASE2
NCT02358161 Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02346344 Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase N/A
NCT02343679 Novartis PhII Ceritinib (LDK378) in R/R ALK+ Hem Malignancies Status WITHDRAWN Phase PHASE2
NCT02342600 SARC029: Trametinib and Pazopanib in Patients With GIST (Gastrointestinal Stromal Tumor) Status WITHDRAWN Phase PHASE2
NCT02340780 Buparlisib in Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT02328963 Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A Status COMPLETED Phase PHASE4
NCT02325505 Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma Status COMPLETED Phase N/A
NCT02325440 Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to Gilenya Status UNKNOWN Phase PHASE4
NCT02325271 Intra-individual Variability and Circadian Rhythm of VEGF Levels and Interaction With Biomarkers Status COMPLETED Phase N/A
NCT02323178 A Study of Eltrombopag in Patients With CMML and Thrombocytopenia Status COMPLETED Phase PHASE1/PHASE2
NCT02323139 A Study of LDE255 in Combination With Azacitidine for High Risk Myelodysplastic Syndrome Patients Status COMPLETED Phase PHASE1
NCT02321839 Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular AMD. Status COMPLETED Phase PHASE4
NCT02308865 Early Palliative Care in Metastatic Lung Cancer in Northern France Status TERMINATED Phase NA
NCT02305446 Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ. Status COMPLETED Phase PHASE3